Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide.

It is now widely accepted that hypertension and endothelial dysfunction are associated with an insulin-resistant state and thus with the development of T2DM (Type 2 diabetes mellitus). Insulin signalling is impaired in target cells and tissues, indicating that common molecular signals are involved. The free radical NO* regulates cell metabolism, insulin signalling and secretion, vascular tone, neurotransmission and immune system function. NO* synthesis is essential for vasodilation, the maintenance of blood pressure and glucose uptake and, thus, if levels of NO* are decreased, insulin resistance and hypertension will result. Decreased blood levels of insulin, increased AngII (angiotensin II), hyperhomocysteinaemia, increased ADMA (asymmetric omega-NG,NG-dimethylarginine) and low plasma L-arginine are all conditions likely to decrease NO* production and which are associated with diabetes and cardiovascular disease. We suggest in the present article that the widely reported beneficial effects of exercise in the improvement of metabolic and cardiovascular health are mediated by enhancing the flux of muscle- and kidney-derived amino acids to pancreatic and vascular endothelial cells aiding the intracellular production of NO*, therefore resulting in normalization of insulin secretion, vascular tone and insulin sensitivity. Exercise may also have an impact on AngII and ADMA signalling and the production of pro- and anti-inflammatory cytokines in muscle, so reducing the progression and development of vascular disease and diabetes. NO* synthesis will be increased during exercise in the vascular endothelial cells so promoting blood flow. We suggest that exercise may promote improvements in health due to positive metabolic and cytokine-mediated effects.

[1]  B. Kingwell,et al.  The effect of the nitric oxide donor sodium nitroprusside on glucose uptake in human primary skeletal muscle cells. , 2009, Nitric oxide : biology and chemistry.

[2]  C. Sobey,et al.  Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke , 2009, Brain Research.

[3]  R. Blumenthal,et al.  Exercise Training for Type 2 Diabetes Mellitus: Impact on Cardiovascular Risk A Scientific Statement From the American Heart Association , 2009, Circulation.

[4]  J. Esplugues,et al.  Regulation of Oxygen Distribution in Tissues by Endothelial Nitric Oxide , 2009, Circulation research.

[5]  R. Curi,et al.  Association of NAD(P)H oxidase with glucose-induced insulin secretion by pancreatic beta-cells. , 2009, Endocrinology.

[6]  G. McConell,et al.  Skeletal muscle glucose uptake during exercise: A focus on reactive oxygen species and nitric oxide signaling , 2009, IUBMB life.

[7]  J. Haefliger,et al.  Swimming Prevents Vulnerable Atherosclerotic Plaque Development in Hypertensive 2-Kidney, 1-Clip Mice by Modulating Angiotensin II Type 1 Receptor Expression Independently From Hemodynamic Changes , 2009, Hypertension.

[8]  M. Turiel,et al.  Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. , 2009, Medical science monitor : international medical journal of experimental and clinical research.

[9]  N. Ruderman,et al.  AMPK and the biochemistry of exercise: implications for human health and disease. , 2009, The Biochemical journal.

[10]  D. Brillante,et al.  Arterial stiffness in insulin resistance: The role of nitric oxide and angiotensin II receptors , 2008, Vascular health and risk management.

[11]  N. Buus,et al.  Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation , 2009, Pharmacological reports : PR.

[12]  J. Tanus-Santos,et al.  Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome. , 2008, Nitric oxide : biology and chemistry.

[13]  K. Ramana,et al.  l‐Arginine prevents metabolic effects of high glucose in diabetic mice , 2008, FEBS letters.

[14]  M. Krause,et al.  Type 1 diabetes: can exercise impair the autoimmune event? The L-arginine/glutamine coupling hypothesis. , 2008 .

[15]  P. H. D. de Bittencourt,et al.  Type 1 diabetes: can exercise impair the autoimmune event? The L‐arginine/glutamine coupling hypothesis , 2008, Cell biochemistry and function.

[16]  C. Dejong,et al.  Glutamine is an important precursor for de novo synthesis of arginine in humans. , 2008, The American journal of clinical nutrition.

[17]  Crystal D. Aultman,et al.  Vascular biology of angiotensin and the impact of physical activity. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[18]  C. Baylis Nitric oxide deficiency in chronic kidney disease. , 2008, American journal of physiology. Renal physiology.

[19]  T. Herbert,et al.  Distinct glucose-dependent stress r esponses revealed by translational profiling in pancreatic b-cells , 2008 .

[20]  Guoyao Wu,et al.  Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. , 2007, The Journal of nutrition.

[21]  Maristela L Onozato,et al.  Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. , 2007, American journal of physiology. Heart and circulatory physiology.

[22]  A. Korac,et al.  Beneficial effects of L‐arginine–nitric oxide‐producing pathway in rats treated with alloxan , 2007, The Journal of physiology.

[23]  M. Brosnan,et al.  Homocysteine metabolism in diabetes. , 2007, Biochemical Society transactions.

[24]  M. Andersen,et al.  Reactive Oxygen Species as a Signal in Glucose-Stimulated Insulin Secretion , 2007, Diabetes.

[25]  J. Sowers,et al.  Role of phosphatidylinositol 3-kinase/Akt pathway in angiotensin II and insulin-like growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells , 2002, Endocrine.

[26]  R. Curi,et al.  Acute exercise stimulates macrophage function: possible role of NF‐κB pathways , 2007 .

[27]  R. Curi,et al.  MRP1/GS‐X pump ATPase expression: is this the explanation for the cytoprotection of the heart against oxidative stress‐induced redox imbalance in comparison to skeletal muscle cells? , 2007, Cell biochemistry and function.

[28]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[29]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[30]  M. Clark,et al.  Acute blockade by endothelin-1 of haemodynamic insulin action in rats , 2007, Diabetologia.

[31]  N. V. van Riel,et al.  Integration of the metabolic and cardiovascular effects of exercise. , 2006, Essays in biochemistry.

[32]  C. Baylis Arginine, arginine analogs and nitric oxide production in chronic kidney disease , 2006, Nature Clinical Practice Nephrology.

[33]  V. Bronte,et al.  Regulation of immune responses by L-arginine metabolism , 2005, Nature Reviews Immunology.

[34]  A. Othman,et al.  l‐Arginine ameliorates oxidative stress in alloxan‐induced experimental diabetes mellitus , 2004, Journal of applied toxicology : JAT.

[35]  M. Brand,et al.  Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. , 2004, Diabetes.

[36]  S. Kahn,et al.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.

[37]  A. Steensberg,et al.  Exercise and hypoxia: effects on leukocytes and interleukin-6-shared mechanisms? , 2002, Medicine and science in sports and exercise.

[38]  M. Wheeler,et al.  Exogenous nitric oxide and endogenous glucose-stimulated beta-cell nitric oxide augment insulin release. , 2002, Diabetes.

[39]  B. Kingwell,et al.  Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects. , 2002, Diabetes.

[40]  M. Febbraio,et al.  Cytokine response to eccentric exercise in young and elderly humans. , 2002, American journal of physiology. Cell physiology.

[41]  Guoyao Wu,et al.  Regulation of nitric oxide synthesis by dietary factors. , 2002, Annual review of nutrition.

[42]  W. Dröge Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[43]  P. Tsao,et al.  Homocysteine Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine , 2001, Circulation.

[44]  J. Méndez,et al.  Regulation of hyperglycemia and dyslipidemia by exogenous L-arginine in diabetic rats. , 2001, Biochimie.

[45]  S. Schoonbroodt,et al.  Oxidative stress interference with the nuclear factor- κB activation pathways , 2000 .

[46]  D. Harrison Oxidant Signaling in Vascular Cell Growth , Death , and Survival A Review of the Roles of Reactive Oxygen Species in Smooth Muscle and Endothelial Cell Mitogenic and Apoptotic Signaling , 2000 .

[47]  G. Spinas The Dual Role of Nitric Oxide in Islet β-Cells , 1999 .

[48]  P. Newsholme,et al.  Importance of glutamine metabolism in murine macrophages and human monocytes to L-arginine biosynthesis and rates of nitrite or urea production. , 1998, Clinical science.

[49]  R. Cannon Role of nitric oxide in cardiovascular disease: focus on the endothelium. , 1998, Clinical chemistry.

[50]  G. Pieper,et al.  Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. , 1997, The Journal of pharmacology and experimental therapeutics.

[51]  C. J. McGrath,et al.  Effect of exchange rate return on volatility spill-over across trading regions , 2012 .

[52]  T. Cruz,et al.  Reactive Oxygen Species Mediate Cytokine Activation of c-Jun NH2-terminal Kinases* , 1996, The Journal of Biological Chemistry.

[53]  A. Quyyumi,et al.  Role of Endothelium‐Derived Nitric Oxide in the Abnormal Endothelium‐Dependent Vascular Relaxation of Patients With Essential Hypertension , 1993, Circulation.

[54]  J. Sowers Insulin resistance and hypertension , 1990, Molecular and Cellular Endocrinology.

[55]  J. Palmer,et al.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects. , 1976, The Journal of clinical investigation.